dave_SLC said:For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.
Thank you — that is the clearest version of this I have read, and I have read a lot of them.
Clinical perspective, offered as context rather than as advice. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.
Dr.SleepRoch said:The useful move here is to separate what is established from what is widely repeated.
Adding a me-too, because a thread of one person's experience is not much use. The detail I would add is minor and it is already implied above.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDr.SleepRoch said:The useful move here is to separate what is established from what is widely repeated.
Adding the part of the answer the thread has not reached. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.
One concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.